OINDPnews Q&A with Copley’s Clair Brooks on in vitro testing for LGWP MDI reformulation
In this article with OINDPnews, our Application Specialist, Dr Clair Brooks, discusses the recent EMA guidance on data requirements associated with the transition to low global warming potential (LGWP) propellants in metered dose inhalers (MDIs) and strategies for the successful application of in vitro testing within this context.
